// App-Quantinova.ai

310 : Mechanism of sorafenib resistance in acute myeloid leukemia

Researchers

Presenter

  • Oscar Lindblad

Principal Investigators

  • Eugenia Cordero

  • Alexandre Puissant

  • Lucy Macaulay

  • Nuzhat N. Kabir

  • Jianmin Sun

  • Karin Haraldsson

  • Ake Borg

  • Fredrik Levander

  • Kimberly Stegmaier

  • Kristian Pietras

  • Lars Ronnstrand

  • Julhash U. Kazi

Medical Centers

  • Lund University Hospital, Lund, Sweden

  • Harvard Medical School, Boston, MA

  • KN Biomedical Research Institute

Locations

  • United States

  • Sweden

  • Bangladesh

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Hematological malignancies

  • Solid malignancies

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • Gedatolisib

  • Sorafenib

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved